BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22151662)

  • 21. A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001.
    Cunningham C; Nemunaitis J
    Hum Gene Ther; 2001 Aug; 12(12):1594-6. PubMed ID: 11529249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-proliferative Effect of Engineered Neural Stem Cells Expressing Cytosine Deaminase and Interferon-β against Lymph Node-Derived Metastatic Colorectal Adenocarcinoma in Cellular and Xenograft Mouse Models.
    Park GT; Kim SU; Choi KC
    Cancer Res Treat; 2017 Jan; 49(1):79-91. PubMed ID: 27188205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzyme/prodrug therapy for head and neck cancer using a catalytically superior cytosine deaminase.
    Hamstra DA; Rice DJ; Fahmy S; Ross BD; Rehemtulla A
    Hum Gene Ther; 1999 Aug; 10(12):1993-2003. PubMed ID: 10466633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isocytosine deaminase Vcz as a novel tool for the prodrug cancer therapy.
    Kazlauskas A; Darinskas A; Meškys R; Tamašauskas A; Urbonavičius J
    BMC Cancer; 2019 Mar; 19(1):197. PubMed ID: 30832616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts.
    Kievit E; Nyati MK; Ng E; Stegman LD; Parsels J; Ross BD; Rehemtulla A; Lawrence TS
    Cancer Res; 2000 Dec; 60(23):6649-55. PubMed ID: 11118048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photodynamic therapy enhances the efficacy of gene-directed enzyme prodrug therapy.
    Christie C; Pomeroy A; Nair R; Berg K; Hirschberg H
    Photodiagnosis Photodyn Ther; 2017 Jun; 18():140-148. PubMed ID: 28257943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential benefits of combining cytosine deaminase/5-fluorocytosine gene therapy and irradiation for prostate cancer: experimental study.
    Kato H; Koshida K; Yokoyama K; Mizokami A; Namiki M
    Int J Urol; 2002 Oct; 9(10):567-76. PubMed ID: 12445236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Sulfatase-1 Improves the Effectiveness of Cytosine Deaminase Suicide Gene Therapy with 5-Fluorocytosine Treatment on Hepatocellular Carcinoma Cell Line HepG2 In Vitro and In Vivo.
    Yang XP; Liu L; Wang P; Ma SL
    Chin Med J (Engl); 2015 May; 128(10):1384-90. PubMed ID: 25963362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular expression of cytosine deaminase results in increased 5-FU production for enhanced enzyme/prodrug therapy.
    Rehemtulla A; Hamstra DA; Kievit E; Davis MA; Ng EY; Dornfeld K; Lawrence TS
    Anticancer Res; 2004; 24(3a):1393-9. PubMed ID: 15274300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit.
    Lee KC; Hamstra DA; Bullarayasamudram S; Bhojani MS; Moffat BA; Dornfeld KJ; Ross BD; Rehemtulla A
    Gene Ther; 2006 Jan; 13(2):127-37. PubMed ID: 16163381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review.
    Zarogoulidis P; Chatzaki E; Hohenforst-Schmidt W; Goldberg EP; Galaktidou G; Kontakiotis T; Karamanos N; Zarogoulidis K
    Cancer Gene Ther; 2012 Sep; 19(9):593-600. PubMed ID: 22744209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncolytic herpes simplex virus expressing yeast cytosine deaminase: relationship between viral replication, transgene expression, prodrug bioactivation.
    Yamada S; Kuroda T; Fuchs BC; He X; Supko JG; Schmitt A; McGinn CM; Lanuti M; Tanabe KK
    Cancer Gene Ther; 2012 Mar; 19(3):160-70. PubMed ID: 22076044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a hypoxia-inducible cytosine deaminase expression vector for gene-directed prodrug cancer therapy.
    Wang D; Ruan H; Hu L; Lamborn KR; Kong EL; Rehemtulla A; Deen DF
    Cancer Gene Ther; 2005 Mar; 12(3):276-83. PubMed ID: 15650767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-targeted Salmonella expressing cytosine deaminase as an anticancer agent.
    King I; Bermudes D; Lin S; Belcourt M; Pike J; Troy K; Le T; Ittensohn M; Mao J; Lang W; Runyan JD; Luo X; Li Z; Zheng LM
    Hum Gene Ther; 2002 Jul; 13(10):1225-33. PubMed ID: 12133275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel mechanism of synergistic cytotoxicity with 5-fluorocytosine and ganciclovir in double suicide gene therapy.
    Boucher PD; Im MM; Freytag SO; Shewach DS
    Cancer Res; 2006 Mar; 66(6):3230-7. PubMed ID: 16540675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bystander effect caused by cytosine deaminase gene and 5-fluorocytosine in vitro is substantially mediated by generated 5-fluorouracil.
    Kuriyama S; Masui K; Sakamoto T; Nakatani T; Kikukawa M; Tsujinoue H; Mitoro A; Yamazaki M; Yoshiji H; Fukui H; Ikenaka K; Mullen CA; Tsujii T
    Anticancer Res; 1998; 18(5A):3399-406. PubMed ID: 9858915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel oncolytic adenovirus expressing Escherichia coli cytosine deaminase exhibits potent antitumor effect on human solid tumors.
    Zhang J; Wei F; Wang H; Li H; Qiu W; Ren P; Chen X; Huang Q
    Cancer Biother Radiopharm; 2010 Aug; 25(4):487-95. PubMed ID: 20735209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new delivery system for 5-fluorouracil using prodrug and converting enzyme.
    Akimoto M; Miyahara T; Arai J; Akimoto A; Hamada H; Yoshida Y; Yoshimura N
    Br J Ophthalmol; 2002 May; 86(5):581-6. PubMed ID: 11973258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of the bifunctional suicide gene CDUPRT increases radiosensitization and bystander effect of 5-FC in prostate cancer cells.
    Xing L; Sun X; Deng X; Kotedia K; Urano M; Koutcher JA; Ling CC; Li GC
    Radiother Oncol; 2009 Sep; 92(3):345-52. PubMed ID: 19433338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo effect of 5-FC combined gene therapy with TNF-α and CD suicide gene on human laryngeal carcinoma cell line Hep-2.
    Chai LP; Wang ZF; Liang WY; Chen L; Chen D; Wang AX; Zhang ZQ
    PLoS One; 2013; 8(4):e61136. PubMed ID: 23593411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.